Cargando…
Advances toward structure-based drug discovery for inflammasome targets
Inflammasome proteins play an important role in many diseases of high unmet need, making them attractive drug targets. However, drug discovery for inflammasome proteins has been challenging in part due to the difficulty in solving high-resolution structures using cryo-EM or crystallography. Recent a...
Autores principales: | Wang, Li, Crackower, Michael A., Wu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600719/ https://www.ncbi.nlm.nih.gov/pubmed/34783859 http://dx.doi.org/10.1084/jem.20211147 |
Ejemplares similares
-
Adoptive cell therapy: Living drugs against cancer
por: Laskowski, Tamara, et al.
Publicado: (2020) -
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue
por: Dartois, Véronique, et al.
Publicado: (2022) -
Surmounting structural barriers to tackle endemic infectious diseases
por: Calderón, Felix, et al.
Publicado: (2021) -
SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021) -
Escape from planned obsolescence: Hepatitis C, the cirrhotic liver, and clonal expansions
por: Branch, Andrea D.
Publicado: (2020)